TrimMedium
YSS remains locked in a Stage 4 downtrend, trading persistently below its declining EMAs with clear sequential lower highs and lower lows. Price is near oversold support yet shows no exhaustion or reversal signs. The medium-term bias stays bearish under the continuation structure, while short-term execution readiness is neutral. Execution should be deferred until a decisive rejection at the 9/20 EMAs confirms further momentum to the downside.
- ↑Q1 revenue $116M (+9% YoY) and backlog $642M (+18%) drive visibility.
- ↑FY26 guide of $545–595M with 70% of revenue committed under existing government deals.
- ↓Gross margin slid to 19% (–4pp YoY) and adjusted EBITDA was –$3.6M.
Full analysis →